Michael Vi/iStock Editorial by way of Getty Photographs
AbbVie (ABBV) is approaching a practically $11B settlement to buy anti-inflammatory drug developer Apogee Therapeutics (APGE), in a deal anticipated to develop into the pharma big’s largest bolt-on acquisition since 2019, The Monetary Instances has reported.
Citing individuals acquainted with the
Source link
#AbbVie #nearing #10.9B #deal #buy #Apogee #Thera #ABBVNYSE
